Status:
COMPLETED
Safety and Tolerability of Artificial Tears in Dry Eye Subjects
Lead Sponsor:
Allergan
Conditions:
Dry Eye Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The safety and tolerability of two new artificial tears will be compared to a currently-available artificial tear in subjects with dry eye. Each subject will receive all three products in a randomly a...
Eligibility Criteria
Inclusion
- Mild, moderate or severe symptoms of dry eye
Exclusion
- Uncontrolled systemic disease
- Contact lens wear
- Participation in another clinical study
Key Trial Info
Start Date :
August 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2009
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT00932477
Start Date
August 1 2009
End Date
September 1 2009
Last Update
August 26 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Diego, California, United States